Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.43 |
| ▸ | TET2 | Q6N021 | 5/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL14946 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL35508 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL8083949 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL29833500 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL15733068 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL11414820 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL5710041 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL35386 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL31053467 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 | |
| Methacrylic Acid SCHEMBL17184295 | 1.00 | LMNA (0.47) | LMNAALDH1A1TGFBR1TET2OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 688 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103623-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2026-04-16 | — | — | US | claimed |
| EP-3867323-B1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2026-03-18 | — | — | EP | claimed |
| US-20260071097-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2026-03-12 | — | — | US | claimed |
| EP-3837327-B1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HENKEL AG & CO KGAA (DE) | 2025-11-12 | — | — | EP | claimed |
| US-12459193-B2 | Method and kit for non-destructive in situ repair (relining) of deteriorated pipelines | APPLIED RESIN S L (ES) | 2025-11-04 | — | — | US | claimed |
| EP-3898740-B1 | (METH)ACRYLIC COMPOSITION COMPRISING A MODIFIED POLYURETHANE | BOSTIK SA (FR) | 2025-03-26 | — | — | EP | claimed |
| EP-4225557-B1 | METHOD AND KIT FOR NON-DESTRUCTIVE IN SITU REPAIR (RELINING) OF DETERIORATED PIPELINES | APPLIED RESIN S L (ES) | 2025-02-19 | — | — | EP | claimed |
| US-12209158-B2 | (Meth)acrylic composition comprising a modified polyurethane | BOSTIK SA (FR) | 2025-01-28 | — | — | US | claimed |
| US-12180395-B2 | Two-part, cyanoacrylate/free radically curable adhesive systems | HENKEL AG & CO. KGAA (DE) | 2024-12-31 | — | — | US | claimed |
| EP-3436500-B1 | TWO PART CURABLE COMPOSITIONS | HENKEL AG & CO KGAA (DE) | 2024-08-07 | — | — | EP | claimed |
| US-20030217808-A1 | Adhesive compositions for bonding passive substrates | Henkel IP & Holding GmbH (DE) | 2003-11-27 | — | — | US | claimed |
| EP-1285037-A2 | ADHESIVE COMPOSITIONS FOR BONDING PASSIVE SUBSTRATES SUCH AS MAGNESIUM ALLOYS | Henkel Loctite Corporation (US) | 2003-02-26 | — | — | EP | claimed |
| WO-2001088050-A2 | ADHESIVE COMPOSITIONS FOR BONDING PASSIVE SUBSTRATES SUCH AS MAGNESIUM ALLOYS | HENKEL LOCTITE CORPORATION (US) | 2001-11-22 | — | — | WO | claimed |
| EP-0081326-B1 | CURING COMPOSITIONS | Lingner + Fischer GmbH (DE) | 1986-05-21 | — | — | EP | claimed |
| US-4569977-A | MONOMER CONTAINING TERMINAL ACRYLIC UNSATURATION AND INTERNAL UNSATURATION | ESCHEM INC. (US) | 1986-02-11 | — | — | US | claimed |
| US-4530988-A | Acrylated ester | ESCHEM INC. (US) | 1985-07-23 | — | — | US | claimed |
| US-4526920-A | Contains poly(meth)acrylic ester of oxy or polyoxyalkane polyol, polymerization initiator, filler | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-07-02 | — | — | US | claimed |
| US-4431787-A | CROSSLINKABLE ACRYLIC ESTER MONOMERS; HIGH SHEER STRENGTH; HEAT RESISTANCE; HIGH CURE SPEED; BONDING METALS | ESCHEM INC. (US) | 1984-02-14 | — | — | US | claimed |
| EP-0081326-A1 | Curing compositions | Lingner + Fischer GmbH (DE) | 1983-06-15 | — | — | EP | claimed |
| US-4209604-A | ACRYLIC ESTERS | ESTECH SPECIALTY CHEMICALS CORPORATION (US) | 1980-06-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071097-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | AHCYL1, CRKL, MMAB | LMNA 804/4885ALDH1A1 142/4885TGFBR1 2364/4885 |
| US-20260103623-A1 | TWO-PART, CYANOACRYLATE/FREE RADICALLY CURABLE ADHESIVE SYSTEMS | HSPA4L, HACL2, CRKL | LMNA 543/4885ALDH1A1 511/4885TGFBR1 396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.